{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:57:56Z","timestamp":1791237476178,"version":"4.1.0"},"reference-count":69,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"crossref","award":["ANR-13-BSV1-0023"],"award-info":[{"award-number":["ANR-13-BSV1-0023"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"crossref","award":["ANR-15-CE14-0005"],"award-info":[{"award-number":["ANR-15-CE14-0005"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011879","name":"LabEx LERMIT","doi-asserted-by":"crossref","award":["ANR-10-LABX-0033"],"award-info":[{"award-number":["ANR-10-LABX-0033"]}],"id":[{"id":"10.13039\/501100011879","id-type":"DOI","asserted-by":"crossref"}]},{"name":"DHU TORINO"},{"name":"Leducq Foundation for Cardiovascular Research","award":["19CVD02"],"award-info":[{"award-number":["19CVD02"]}]},{"name":"EU MILEAGE","award":["project #734931"],"award-info":[{"award-number":["project #734931"]}]},{"name":"Lefoulon Delalande fellowship","award":["Graduate Student Fellowship"],"award-info":[{"award-number":["Graduate Student Fellowship"]}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,8,3]]},"abstract":"<jats:p>\n                    Anthracyclines, such as doxorubicin (Dox), are widely used chemotherapeutic agents for the treatment of solid tumors and hematologic malignancies. However, they frequently induce cardiotoxicity leading to dilated cardiomyopathy and heart failure. This study sought to investigate the role of the exchange protein directly activated by cAMP (EPAC) in Dox-induced cardiotoxicity and the potential cardioprotective effects of EPAC inhibition. We show that Dox induces DNA damage and cardiomyocyte cell death with apoptotic features. Dox also led to an increase in both cAMP concentration and EPAC1 activity. The pharmacological inhibition of EPAC1 (with CE3F4) but not EPAC2 alleviated the whole Dox-induced pattern of alterations. When administered\n                    <jats:italic>in vivo<\/jats:italic>\n                    , Dox-treated WT mice developed a dilated cardiomyopathy which was totally prevented in EPAC1 knock-out (KO) mice. Moreover, EPAC1 inhibition potentiated Dox-induced cell death in several human cancer cell lines. Thus, EPAC1 inhibition appears as a potential therapeutic strategy to limit Dox-induced cardiomyopathy without interfering with its antitumoral activity.\n                  <\/jats:p>","DOI":"10.7554\/elife.83831","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T06:15:13Z","timestamp":1691475313000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.83831","source":"Crossref","is-referenced-by-count":14,"title":["EPAC1 inhibition protects the heart from doxorubicin-induced toxicity"],"prefix":"10.7554","volume":"12","author":[{"given":"Marianne","family":"Mazevet","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Belhadef","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxance","family":"Ribeiro","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-2352","authenticated-orcid":true,"given":"Delphine","family":"Dayde","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Llach","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Laudette","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04d73z393","id-type":"ROR","asserted-by":"publisher"}],"name":"Institut des Maladies Metaboliques et Cardiovasculaires - I2MC, INSERM, Universit\u00e9 de Toulouse","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Belleville","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001z21q04","id-type":"ROR","asserted-by":"publisher"}],"name":"Innovations Th\u00e9rapeutiques en H\u00e9mostase - UMR-S 1140, INSERM, Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mateo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Gressette","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lefebvre","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Chen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0168r3w48","id-type":"ROR","asserted-by":"publisher"}],"name":"Basic Cardiac Research UCSD School of Medicine La Jolla","place":["San Diego, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christilla","family":"Bachelot-Loza","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001z21q04","id-type":"ROR","asserted-by":"publisher"}],"name":"Innovations Th\u00e9rapeutiques en H\u00e9mostase - UMR-S 1140, INSERM, Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rucker-Martin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Saclay","place":["Le Kremlin Bic\u00eatre, France"]},{"id":[{"id":"https:\/\/ror.org\/02ndr3r66","id-type":"ROR","asserted-by":"publisher"}],"name":"Inserm UMR_S 999, H\u00f4pital Marie Lannelongue","place":["Le Plessis Robinson, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Lezoualch","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04d73z393","id-type":"ROR","asserted-by":"publisher"}],"name":"Institut des Maladies Metaboliques et Cardiovasculaires - I2MC, INSERM, Universit\u00e9 de Toulouse","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Crozatier","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Benitah","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2109-8073","authenticated-orcid":true,"given":"Marie-Catherine","family":"Vozenin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/022vd9g66","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratoire de Radio-Oncologie, CHUV","place":["Lausanne, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2086-9865","authenticated-orcid":true,"given":"Rodolphe","family":"Fischmeister","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Gomez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lemaire","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]},{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, UVSQ, Inserm","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1960-0121","authenticated-orcid":true,"given":"Eric","family":"Morel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xjwb503","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris-Saclay, Inserm, UMR-S 1180","place":["Orsay, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1124\/mol.114.095158","article-title":"Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo","volume":"87","author":"Almahariq","year":"2015","journal-title":"Molecular Pharmacology"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/abbs\/gmv115","article-title":"The pleiotropic role of exchange protein directly activated by cAMP 1 (EPAC1) in cancer: implications for therapeutic intervention","volume":"48","author":"Almahariq","year":"2016","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1755-148X.2011.00863.x","article-title":"Epac1 promotes melanoma metastasis via modification of heparan sulfate","volume":"24","author":"Baljinnyam","year":"2011","journal-title":"Pigment Cell & Melanoma Research"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/pcmr.12250","article-title":"Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling","volume":"27","author":"Baljinnyam","year":"2014","journal-title":"Pigment Cell & Melanoma Research"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.1074\/jbc.M114.548636","article-title":"Identification and validation of modulators of exchange protein activated by cAMP (Epac) activity: structure-function implications for Epac activation and inhibition","volume":"289","author":"Brown","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"bib6","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1521020","article-title":"Oxidative stress and cellular response to doxorubicin: A common factor in the complex milieu of anthracycline cardiotoxicity","volume":"2017","author":"Cappetta","year":"2017","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/med.21280","article-title":"Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy","volume":"34","author":"Carvalho","year":"2014","journal-title":"Medicinal Research Reviews"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.bbamcr.2006.11.013","article-title":"Necrotic death without mitochondrial dysfunction-delayed death of cardiac myocytes following oxidative stress","volume":"1773","author":"Casey","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"14144","DOI":"10.1073\/pnas.0812536106","article-title":"The cAMP binding protein Epac regulates cardiac myofilament function","volume":"106","author":"Cazorla","year":"2009","journal-title":"PNAS"},{"key":"bib10","first-page":"4592","article-title":"Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio","volume":"62","author":"Childs","year":"2002","journal-title":"Cancer Research"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev.biophys.33.110502.140357","article-title":"Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases","volume":"33","author":"Corbett","year":"2004","journal-title":"Annual Review of Biophysics and Biomolecular Structure"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"44192","DOI":"10.1074\/jbc.M112.422956","article-title":"Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac","volume":"287","author":"Courilleau","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbrc.2013.09.107","article-title":"The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1)","volume":"440","author":"Courilleau","year":"2013","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/24884","article-title":"Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP","volume":"396","author":"de Rooij","year":"1998","journal-title":"Nature"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.onc.1210638","article-title":"Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis","volume":"27","author":"Deniaud","year":"2008","journal-title":"Oncogene"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.taap.2012.10.025","article-title":"Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model","volume":"266","author":"Desai","year":"2013","journal-title":"Toxicology and Applied Pharmacology"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1101\/gad.269894.115","article-title":"Mitochondrial biogenesis and dynamics in the developing and diseased heart","volume":"29","author":"Dorn","year":"2015","journal-title":"Genes & Development"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/CIRCRESAHA.116.309859","article-title":"Multifunctional mitochondrial epac1 controls myocardial cell death","volume":"120","author":"Fazal","year":"2017","journal-title":"Circulation Research"},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-016-0786-0","article-title":"Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT\/Cyclin D1\/CDK4 pathway in vitro and in vivo","volume":"33","author":"Gao","year":"2016","journal-title":"Medical Oncology"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0301-4622(90)80012-v","article-title":"Structure of the adriamycin-cardiolipin complex: Role in mitochondrial toxicity","volume":"35","author":"Goormaghtigh","year":"1990","journal-title":"Biophysical Chemistry"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejphar.2014.05.017","article-title":"Cardioprotection against doxorubicin by metallothionein Is associated with preservation of mitochondrial biogenesis involving PGC-1\u03b1 pathway","volume":"737","author":"Guo","year":"2014","journal-title":"European Journal of Pharmacology"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"38590","DOI":"10.1074\/jbc.M112.377903","article-title":"Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons","volume":"287","author":"Huelsenbeck","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1089\/thy.2017.0528","article-title":"Deletion of Rap1b, but not Rap1a or Epac1, Reduces protein kinase a-mediated thyroid cancer","volume":"28","author":"Huk","year":"2018","journal-title":"Thyroid"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"46354","DOI":"10.18632\/oncotarget.10128","article-title":"Epac1 links prostaglandin E2 to \u03b2-catenin-dependent transcription during epithelial-to-mesenchymal transition","volume":"7","author":"Jansen","year":"2016","journal-title":"Oncotarget"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mito.2016.10.008","article-title":"Effects of doxorubicin on cardiac muscle subsarcolemmal and intermyofibrillar mitochondria","volume":"34","author":"Kavazis","year":"2017","journal-title":"Mitochondrion"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1126\/science.282.5397.2275","article-title":"A family of cAMP-binding proteins that directly activate Rap1","volume":"282","author":"Kawasaki","year":"1998","journal-title":"Science"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11010-017-2959-3","article-title":"Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis","volume":"430","author":"Kumar","year":"2017","journal-title":"Molecular and Cellular Biochemistry"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11010-018-3294-z","article-title":"Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment","volume":"447","author":"Kumar","year":"2018","journal-title":"Molecular and Cellular Biochemistry"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/cvr\/cvu242","article-title":"Exchange protein directly activated by cAMP 1 promotes autophagy during cardiomyocyte hypertrophy","volume":"105","author":"Laurent","year":"2015","journal-title":"Cardiovascular Research"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12012-007-0009-1","article-title":"Role of mtDNA lesions in anthracycline cardiotoxicity","volume":"7","author":"Lebrecht","year":"2007","journal-title":"Cardiovascular Toxicology"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"H1273","DOI":"10.1152\/ajpheart.00738.2005","article-title":"DNA damage is an early event in doxorubicin-induced cardiac myocyte death","volume":"291","author":"L\u2019Ecuyer","year":"2006","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1161\/CIRCULATIONAHA.117.030352","article-title":"Phosphoinositide 3-Kinase Gamma Inhibition protects from anthracycline cardiotoxicity and reduces tumor growth","volume":"138","author":"Li","year":"2018","journal-title":"Circulation"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"8290","DOI":"10.1074\/jbc.M308033200","article-title":"Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes","volume":"279","author":"Lim","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S1470-2045(10)70204-7","article-title":"Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial","volume":"11","author":"Lipshultz","year":"2010","journal-title":"The Lancet. Oncology"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"H1956","DOI":"10.1152\/ajpheart.00407.2008","article-title":"ERKs\/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes","volume":"295","author":"Liu","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.yjmcc.2018.11.019","article-title":"Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity","volume":"126","author":"Llach","year":"2019","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/ncb1007","article-title":"Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha","volume":"5","author":"Maillet","year":"2003","journal-title":"Nature Cell Biology"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1210\/me.2014-1346","article-title":"Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes","volume":"29","author":"Mangmool","year":"2015","journal-title":"Molecular Endocrinology"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline Chemotherapy and Cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1161\/CIRCRESAHA.107.164947","article-title":"Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy","volume":"102","author":"M\u00e9trich","year":"2008","journal-title":"Circulation Research"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.radonc.2014.01.025","article-title":"Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis","volume":"111","author":"Monceau","year":"2014","journal-title":"Radiotherapy and Oncology"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/01.RES.0000194325.31359.86","article-title":"cAMP-binding protein Epac induces cardiomyocyte hypertrophy","volume":"97","author":"Morel","year":"2005","journal-title":"Circulation Research"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1021\/bi0361665","article-title":"Interaction model for anthracycline activity against DNA topoisomerase II","volume":"43","author":"Moro","year":"2004","journal-title":"Biochemistry"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCHEARTFAILURE.114.001180","article-title":"Sexual dimorphism of doxorubicin-mediated cardiotoxicity: potential role of energy metabolism remodeling","volume":"8","author":"Moulin","year":"2015","journal-title":"Circulation. Heart Failure"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrc2607","article-title":"Targeting DNA topoisomerase II in cancer chemotherapy","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nature Reviews. Cancer"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1074\/jbc.M806994200","article-title":"Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II","volume":"284","author":"Oestreich","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1172\/JCI64784","article-title":"Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses","volume":"124","author":"Okumura","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.yjmcc.2011.10.016","article-title":"Epac enhances excitation-transcription coupling in cardiac myocytes","volume":"52","author":"Pereira","year":"2012","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.2217\/fon-2018-0210","article-title":"Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling","volume":"14","author":"Reichardt","year":"2018","journal-title":"Future Oncology"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1124\/mol.108.045286","article-title":"Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells","volume":"74","author":"Riganti","year":"2008","journal-title":"Molecular Pharmacology"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1152\/physrev.00025.2017","article-title":"Intracellular cAMP Sensor EPAC: Physiology, pathophysiology, and therapeutics development","volume":"98","author":"Robichaux","year":"2018","journal-title":"Physiological Reviews"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"52095","DOI":"10.1074\/jbc.M405697200","article-title":"Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels","volume":"279","author":"Rochais","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tips.2015.03.005","article-title":"Anthracyclines\/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms","volume":"36","author":"Rochette","year":"2015","journal-title":"Trends in Pharmacological Sciences"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.yjmcc.2011.07.016","article-title":"CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes","volume":"51","author":"Sag","year":"2011","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-pharmtox-030620-104842","article-title":"Preventing and treating anthracycline cardiotoxicity: New insights","volume":"61","author":"Sawicki","year":"2021","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/j.pain.0000000000001160","article-title":"Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy","volume":"159","author":"Singhmar","year":"2018","journal-title":"Pain"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"24248","DOI":"10.1074\/jbc.M109.094581","article-title":"Differential roles of Epac in regulating cell death in neuronal and myocardial cells","volume":"285","author":"Suzuki","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1200\/JCO.1997.15.4.1318","article-title":"Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer","volume":"15","author":"Swain","year":"1997","journal-title":"Journal of Clinical Oncology"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1200\/JCO.2005.02.3879","article-title":"Dexrazoxane-associated risk for acute myeloid leukemia\/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin\u2019s disease","volume":"25","author":"Tebbi","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.yjmcc.2006.06.009","article-title":"New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics","volume":"41","author":"Tokarska-Schlattner","year":"2006","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"18613","DOI":"10.1073\/pnas.1210209109","article-title":"Isoform-specific antagonists of exchange proteins directly activated by cAMP","volume":"109","author":"Tsalkova","year":"2012","journal-title":"PNAS"},{"key":"bib63","doi-asserted-by":"publisher","DOI":"10.1038\/srep36552","article-title":"Inhibition of Epac1 suppresses mitochondrial fission and reduces neointima formation induced by vascular injury","volume":"6","author":"Wang","year":"2016","journal-title":"Scientific Reports"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.bmcl.2017.02.065","article-title":"Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets","volume":"27","author":"Wang","year":"2017","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1016\/j.bbamcr.2013.08.016","article-title":"DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac","volume":"1833","author":"Wartlick","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00005-009-0051-8","article-title":"Cardiomyocyte death in doxorubicin-induced cardiotoxicity","volume":"57","author":"Zhang","year":"2009","journal-title":"Archivum Immunologiae et Therapiae Experimentalis"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nature Medicine"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1002\/jcb.27880","article-title":"A novel agent attenuates cardiotoxicity and improves antitumor activity of doxorubicin in breast cancer cells","volume":"120","author":"Zhang","year":"2019","journal-title":"Journal of Cellular Biochemistry"},{"key":"bib69","doi-asserted-by":"publisher","DOI":"10.1038\/srep09344","article-title":"Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: Defining the ESI-09 \u201cTherapeutic Window.\u201d","volume":"5","author":"Zhu","year":"2015","journal-title":"Scientific Reports"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/83831\/elife-83831-v3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/83831\/elife-83831-v3.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/83831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T10:46:01Z","timestamp":1697453161000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/83831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":69,"alternative-id":["10.7554\/eLife.83831"],"URL":"https:\/\/doi.org\/10.7554\/elife.83831","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.16.448655","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2021.06.16.448655","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2021.06.16.448655","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.83831.sa2","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.83831.sa0","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.83831.sa1","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e83831"}}